Squamocolumnar junction visibility, age, and implications for cervical cancer screening programs.

Area of Science:

• Gynecology
• Oncology
• Public Health

Background:

• Cervical cancer screening often relies on visual assessment for triage.
• Current guidelines typically recommend screening up to age 65.
• The squamocolumnar junction (SCJ) is crucial for detecting cervical precancers and cancers.

Purpose of the Study:

• To assess the impact of age on squamocolumnar junction (SCJ) visibility in cervical images.
• To evaluate how SCJ visibility affects cervical cancer screening effectiveness.
• To inform potential adjustments to upper age limits in cervical cancer screening guidelines.

Main Methods:

• Analysis of cervical images from three National Cancer Institute funded studies (ALTS, NHS, Biopsy study).
• Colposcopist reviewers assessed the visibility of the SCJ in participants across different age groups.
• Comparison of SCJ visibility between live colposcopic examination and static image review.

Main Results:

• SCJ visibility significantly declines with increasing age, with majority having partial visibility by late 40s.
• The most substantial decrease in SCJ visibility occurred between ages 40-54, varying by study.
• Live colposcopic exams showed significantly higher SCJ visibility compared to static image review.

Conclusions:

• Reduced SCJ visibility with age complicates diagnosis and management of cervical precancers.
• Cervical cancer screening programs using visual assessment may need to reconsider upper age limits.
• Adequate personnel and equipment are essential for managing patients with poor SCJ visibility.